HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

2,5-di-tert-butylhydroquinone

Ca2+-ATPase antagonist
Also Known As:
1,4-benzenediol, 2,5-bis(1,1-dimethylethyl)-; 1,4-dihydroxy-2,5-di-tert-butylbenzene; 2,5-di(tert-butyl)-1,4-benzohydroquinone; 2,5-di-t-butylquinol; 2,5-di-tert-butyl-1,4-benzenediol; 2,5-di-tert-butyl-1,4-benzohydroquinone; 2,5-di-tert-butylbenzene-1,4-diol; 2,5-di-tert-butylquinol; DTBHQ; NSC-11; di-t-butylhydroquinone; di-tert-butylhydroquinone; tBuBHQ
Networked: 8 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Peng, Sisi: 1 article (01/2020)
2. Shen, Ying: 1 article (01/2020)
3. Wang, Min: 1 article (01/2020)
4. Zhang, Junjian: 1 article (01/2020)
5. Chang, Hong-Tai: 1 article (10/2013)
6. Chen, I-Li: 1 article (10/2013)
7. Chou, Chiang-Ting: 1 article (10/2013)
8. Huang, Jong-Khing: 1 article (10/2013)
9. Jan, Chung-Ren: 1 article (10/2013)
10. Kuo, Daih-Huang: 1 article (10/2013)

Related Diseases

1. Muscle Weakness
2. Neoplasms (Cancer)
3. Leukemia
4. Cognitive Dysfunction
5. Glioma (Gliomas)

Related Drugs and Biologics

1. Neurocalcin
2. Type C Phospholipases
3. Resveratrol
4. 1- (6- ((3- methoxyestra- 1,3,5(10)- trien- 17- yl)amino)hexyl)- 1H- pyrrole- 2,5- dione
5. Thapsigargin
6. Biomarkers (Surrogate Marker)
7. Thimerosal (Thiomersal)
8. Protein Kinase C
9. Phosphatidylserines
10. Histamine (Histamine Dihydrochloride)

Related Therapies and Procedures

1. Oral Administration